- 2016-02-08 Dilaforette AB
Dilaforette appoints new VP of Development
- 2016-01-28 Promimic AB
Promimic launches dental implants with SIN
- 2016-01-19 Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB appoints Dr Richard Jones as CEO
- 2015-12-09 Umecrine Cognition AB
Umecrine Cognition announces grant of a US patent protecting its lead candidate drug GR3027. The use of GR3027 as a novel therapy of hepatic encephalopathy is also acknowledged in recognized scientific publications.